Published in Eur J Biochem on July 01, 1986
Cell-mediated crystallization of calcium oxalate in plants Plant Cell (1999) 2.33
Alteration of urinary macromolecules by adsorption on surfaces, probably an important factor in urolithiasis. Urolithiasis (2013) 0.79
Nomogram for derivation of renal threshold phosphate concentration. Lancet (1975) 3.20
A Combined Immunofluorescence-DNA-Fluorescence Staining Technique for Enumeration of Thiobacillus ferrooxidans in a Population of Acidophilic Bacteria. Appl Environ Microbiol (1987) 2.85
Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J (1980) 2.29
Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone Miner (1986) 2.23
Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.). Lancet (1979) 2.02
Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia. Lancet (1983) 2.00
Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet (1987) 1.90
Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.). Lancet (1979) 1.78
Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia. Lancet (1968) 1.77
Manganese oxidation by spores and spore coats of a marine bacillus species. Appl Environ Microbiol (1986) 1.74
Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma. Cancer (1985) 1.74
Enzymatic iron oxidation by Leptothrix discophora: identification of an iron-oxidizing protein. Appl Environ Microbiol (1992) 1.68
Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats. Calcif Tissue Int (1980) 1.65
Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun (1989) 1.64
Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone. Clin Orthop Relat Res (1987) 1.55
The assessment of phosphate reabsorption. Clin Chim Acta (1969) 1.42
[Consensus conference on osteoporosis]. Ned Tijdschr Geneeskd (1986) 1.39
Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD). Br Med J (Clin Res Ed) (1987) 1.33
Palliative pamidronate treatment in patients with bone metastases from breast cancer. J Clin Oncol (1993) 1.32
Enhancement of the inhibitory action of APD on the transformation of osteoclast precursors into resorbing cells after dimethylation of the amino group. Bone Miner (1987) 1.31
Skeletal matrices, muci, and the origin of invertebrate calcification. Proc Natl Acad Sci U S A (1996) 1.22
Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate. J Bone Miner Res (1988) 1.22
Natriuretic effect of calcitonin in man. N Engl J Med (1971) 1.21
Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis (1999) 1.20
Stimulation of bone resorption by inflamed nasal mucosa, dermonecrotic toxin-containing conditioned medium from Pasteurella multocida, and purified dermonecrotic toxin from P. multocida. Infect Immun (1987) 1.19
APD in Paget's disease of bone. Role of the mononuclear phagocyte system? Arthritis Rheum (1980) 1.18
Oxidation of Manganese and Iron by Leptothrix discophora: Use of N,N,N',N'-Tetramethyl-p-Phenylenediamine as an Indicator of Metal Oxidation. Appl Environ Microbiol (1990) 1.18
Mucins and molluscan calcification. Molecular characterization of mucoperlin, a novel mucin-like protein from the nacreous shell layer of the fan mussel Pinna nobilis (Bivalvia, pteriomorphia). J Biol Chem (2000) 1.17
Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD. Bone Miner (1989) 1.15
Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride. Am J Med (1987) 1.13
Characteristics and bisphosphonate treatment of a patient with juvenile osteoporosis. J Clin Endocrinol Metab (1985) 1.12
Bladder calculi in augmentation cystoplasty in children. Urology (2000) 1.08
Crystal agglomeration is a major element in calcium oxalate urinary stone formation. Kidney Int (1990) 1.06
Preservation of antigenic properties of macromolecules over 70 Myr. Nature (1974) 1.06
Paget's bone disease treated with diphosphonate and calcitonin. Lancet (1976) 1.05
Regulation of the C3 nephritic factor stabilized C3/C5 convertase of complement by purified human erythrocyte C3b receptor. Clin Exp Immunol (1982) 1.03
Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate. Clin Sci (1969) 1.02
Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium. Am J Kidney Dis (2000) 1.02
Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet (1986) 1.00
Bone scintigraphy and radiology in Paget's disease of bone: a review. Am J Physiol Imaging (1988) 0.99
Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro. J Clin Invest (1982) 0.98
Abnormal urine flow in boys with distal hypospadias before and after correction. J Urol (2006) 0.98
The role in CaCO3 crystallization of an acid Ca2+-binding polysaccharide associated with coccoliths of Emiliania huxleyi. Eur J Biochem (1982) 0.98
Vanished testis: be aware of an abdominal testis. J Urol (2000) 0.96
A marriage of bone and nacre. Nature (1998) 0.94
Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD. Bone Miner (1986) 0.94
Relation between signs and symptoms in Paget's disease of bone. Q J Med (1986) 0.93
Regression of bone lesions in Gaucher's disease during treatment with aminohydroxypropylidene bisphosphonate. Lancet (1984) 0.93
A simple slide-rule method for the assessment of renal tubular reaborption of phosphate in man. Clin Chim Acta (1977) 0.93
Diversity, seasonality and sites of attachment of adult ixodid ticks on dogs in the central region of the Free State Province, South Africa. Onderstepoort J Vet Res (2001) 0.92
Renal phosphate excretion in man. Folia Med Neerl (1972) 0.92
Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone. Eur J Clin Invest (1982) 0.92
Cytokine production induced by binding and processing of calcium oxalate crystals in cultured macrophages. Am J Kidney Dis (2001) 0.91
Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment. J Clin Endocrinol Metab (1987) 0.91
Familial benign hypercalcaemia. Study of a large family. Q J Med (1983) 0.91
Primary oxalosis: clinical and biochemical response to high-dose pyridoxine therapy. Metabolism (1979) 0.91
Efficacy of a novel formulation of metaflumizone plus amitraz for the treatment of demodectic mange in dogs. Vet Parasitol (2007) 0.91
Effect of a diphosphonate on para-articular ossification after total hip replacement. Acta Orthop Scand (1974) 0.90
Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers. Urology (1998) 0.90
The use of bisphosphonates in the treatment of osteoporosis. Bone (1992) 0.89
Isolation and characterization of a Ca2+ -binding polysaccharide associated with coccoliths of Emiliania huxleyi (Lohmann) Kamptner. Eur J Biochem (1976) 0.89
Treatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphonate. J Clin Oncol (1986) 0.88
Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP). Neth J Med (1974) 0.88
Efficacy of a novel formulation of metaflumizone plus amitraz for the treatment of sarcoptic mange in dogs. Vet Parasitol (2007) 0.87
Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment. Eur J Cancer Clin Oncol (1986) 0.87
Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium. Calcif Tissue Int (1982) 0.87
Modulation of calcium oxalate monohydrate crystallization kinetics in vitro. Kidney Int (1988) 0.87
Raman spectroscopic analysis identifies testicular microlithiasis as intratubular hydroxyapatite. J Urol (2004) 0.86
Ectopic production of 1,25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcemia. Cancer (1987) 0.86
Radiological demonstration of healing in Paget's disease of bone treated with APD. Br J Radiol (1985) 0.86
Epidemiology of tick-borne diseases of cattle in Botshabelo and Thaba Nchu in the Free State Province. Onderstepoort J Vet Res (1998) 0.86
Cell type-specific acquired protection from crystal adherence by renal tubule cells in culture. Kidney Int (1999) 0.85
Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers. Urology (1995) 0.85
Paroxysmal non-epileptic events in children: a retrospective study over a period of 10 years. J Paediatr Child Health (2000) 0.85
Untreated Paget disease of bone studied by scintigraphy. Radiology (1984) 0.85
Inorganic pyrophosphatase in mineralizing hamster molars. 3. Influence of diphosphonates. Calcif Tissue Res (1973) 0.84
Relationship of inorganic pyrophosphatase and alkaline phosphatase activities in hamster molars. Calcif Tissue Res (1970) 0.84
Identification of bladder wall layers by Raman spectroscopy. J Urol (2002) 0.84
Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonate. J Bone Miner Res (1989) 0.84
Physicochemical effects of a new slow-release potassium phosphate preparation (UroPhos-K) in absorptive hypercalciuria. J Bone Miner Res (1995) 0.84
Evaluation of the efficacy of an imidacloprid 10%/moxidectin 1% spot-on against Otodectes cynotisin cats. Parasitol Res (2003) 0.84
Sialic acid and crystal binding. Kidney Int (2000) 0.84
Modulation of calcium oxalate monohydrate crystallization kinetics by urine of preterm neonates. Am J Kidney Dis (2001) 0.83
Urodynamic follow-up of experimental urethral obstruction in individual guinea pigs. Neurourol Urodyn (2001) 0.83
In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferation. Immunology (1982) 0.83
The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer. Eur J Cancer (1991) 0.82
Modulation of the production of a parathyroid hormone-like protein in human squamous carcinoma cell lines by interaction with fibroblasts. Cancer Res (1990) 0.82
Apposition and resorption of bone during oral treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Calcif Tissue Int (1983) 0.81
Soluble intracrystalline polysaccharides from coccoliths of Coccolithus huxleyi (Lohmann) Kamptner (I). Calcif Tissue Res (1973) 0.81
Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants. J Bone Miner Res (1991) 0.81
Calcium oxalate stone agglomeration reflects stone-forming activity: citrate inhibition depends on macromolecules larger than 30 kilodalton. Am J Kidney Dis (1994) 0.81
A comparison of Ixodes rubicundus (Acari: Ixodidae) infestations on Friesian and Bonsmara cattle in South Africa. Exp Appl Acarol (1995) 0.80
Combined diphosphonate and calcitonin therapy for Paget's disease of bone. Calcif Tissue Res (1976) 0.80
Effects of long-term porcine calcitonin administration in patients with Paget's disease or osteoporosis. Calcif Tissue Res (1970) 0.80
Large-scale fractionation of molluscan shell matrix. Protein Expr Purif (2001) 0.80
Polysaccharide localization, coccolith formation, and Golgi dynamics in the coccolithophorid Hymenomonas carterae. J Ultrastruct Res (1983) 0.80
Methods for measuring crystallization in urolithiasis research: why, how and when? Eur Urol (2001) 0.79